[go: up one dir, main page]

MX2017011040A - Agente para el tratamiento de infeccion respiratoria. - Google Patents

Agente para el tratamiento de infeccion respiratoria.

Info

Publication number
MX2017011040A
MX2017011040A MX2017011040A MX2017011040A MX2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A MX 2017011040 A MX2017011040 A MX 2017011040A
Authority
MX
Mexico
Prior art keywords
respiratory infection
treating agent
infection treating
agent
treatment
Prior art date
Application number
MX2017011040A
Other languages
English (en)
Other versions
MX380385B (es
Inventor
Kume Kota
Yoshida Hisao
ANDO Hirotaka
Tanaka Yuta
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of MX2017011040A publication Critical patent/MX2017011040A/es
Publication of MX380385B publication Critical patent/MX380385B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

[Problema] La presente invención se refiere a un agente para el tratamiento de infección respiratoria más seguro y más efectivo. [Solución] Un agente para el tratamiento de infección respiratoria contiene, como un ingrediente activo, ácido 7-[(3S,4S)-3-{(ciclopropilamino)metil}-4-fluoropirrolidin-1-il]-6 -fluoro-1-(2-fluoroetil)-8-metoxi-4-oxo-1,4-dihidroquinolin-3-car boxílico o una sal farmacéuticamente aceptable del mismo.
MX2017011040A 2015-03-13 2016-03-11 Agente para el tratamiento de infeccion respiratoria. MX380385B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015051206 2015-03-13
JP2015136944 2015-07-08
PCT/JP2016/057797 WO2016148066A1 (ja) 2015-03-13 2016-03-11 呼吸器感染症治療剤

Publications (2)

Publication Number Publication Date
MX2017011040A true MX2017011040A (es) 2017-11-10
MX380385B MX380385B (es) 2025-03-12

Family

ID=56920174

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011040A MX380385B (es) 2015-03-13 2016-03-11 Agente para el tratamiento de infeccion respiratoria.

Country Status (15)

Country Link
US (3) US20180042918A1 (es)
EP (1) EP3269369A4 (es)
JP (1) JP6077725B1 (es)
KR (1) KR102532681B1 (es)
CN (2) CN113975277B (es)
AU (1) AU2016234411C1 (es)
BR (1) BR112017019205A2 (es)
CA (1) CA2978261A1 (es)
EA (1) EA201791995A1 (es)
IL (1) IL253878A0 (es)
MX (1) MX380385B (es)
MY (1) MY191848A (es)
PH (1) PH12017501505A1 (es)
SG (2) SG11201706951XA (es)
WO (1) WO2016148066A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110891571A (zh) * 2017-06-16 2020-03-17 杏林制药株式会社 吸入性肺炎、肺化脓或肺脓肿的治疗剂
WO2018230686A1 (ja) * 2017-06-16 2018-12-20 杏林製薬株式会社 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
ID16655A (id) 1996-04-24 1997-10-30 Daiichi Seiyaku Co Turunan-turunan sikloalkilaminometilpirolidina
ATE443064T1 (de) * 2002-03-18 2009-10-15 Kyorin Seiyaku Kk 10-(3-cyclo propyl amino methyl-1-pyrrolidinyl) pyridobenzoxazin carbonsäure derivat mit wirkung gegen resistente bakterien
PT1666477E (pt) * 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
DE102007027618A1 (de) 2007-06-12 2008-12-18 Rehau Ag + Co Verfahren zur Vorbehandlung von zu lackierenden polymeren Oberflächen
WO2013006854A2 (en) * 2011-07-07 2013-01-10 Indiana University Research And Technology Corporation Compositions and methods for treating enterobacteriaceae
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
WO2014174848A1 (ja) * 2013-04-25 2014-10-30 杏林製薬株式会社 錠剤

Also Published As

Publication number Publication date
BR112017019205A2 (pt) 2018-04-24
CN107427507A (zh) 2017-12-01
SG11201706951XA (en) 2017-09-28
CA2978261A1 (en) 2016-09-22
EA201791995A1 (ru) 2017-12-29
IL253878A0 (en) 2017-10-31
WO2016148066A1 (ja) 2016-09-22
EP3269369A1 (en) 2018-01-17
AU2016234411C1 (en) 2020-04-30
EP3269369A4 (en) 2018-11-07
CN113975277A (zh) 2022-01-28
US20190076421A1 (en) 2019-03-14
AU2016234411A1 (en) 2017-09-07
US10918634B2 (en) 2021-02-16
US20210052572A1 (en) 2021-02-25
JP6077725B1 (ja) 2017-02-08
KR20170123695A (ko) 2017-11-08
CN107427507B (zh) 2021-12-17
PH12017501505B1 (en) 2018-02-05
MX380385B (es) 2025-03-12
US20180042918A1 (en) 2018-02-15
CN113975277B (zh) 2024-10-18
SG10201908007UA (en) 2019-10-30
AU2016234411B2 (en) 2020-01-30
MY191848A (en) 2022-07-18
JPWO2016148066A1 (ja) 2017-04-27
KR102532681B1 (ko) 2023-05-15
PH12017501505A1 (en) 2018-02-05

Similar Documents

Publication Publication Date Title
CL2019001565A1 (es) Composición farmacéutica para prevenir o tratar el cáncer, comprendiendo el polímorfo cristalino del hexoxido tetraarsénico.
MX2022010831A (es) Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
MX2016016593A (es) Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos.
MX2020009010A (es) Formulaciones inyectables de larga duracion que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
MX394222B (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
GT201700280A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma
PH12015501891A1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12016502003A1 (en) Novel bacteriophage and composition containing same
BR112015017519A2 (pt) compostos e métodos para o tratamento de infecções bacterianas
PH12015501890A1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12016501999B1 (en) Novel bacteriophage and composition containing same
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
PH12016502001B1 (en) Novel bacteriophage and composition comprising same
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
EA201791051A1 (ru) Способ лечения, профилактики или снижения риска возникновения кожной инфекции
MX2017011040A (es) Agente para el tratamiento de infeccion respiratoria.
BR112017021620A2 (pt) sais altamente solúveis em água de um bloqueador de canal de cálcio de fenilalquilamina de ação curta e usos dos mesmos
EA201992234A1 (ru) Средство для профилактики миопии, лечения миопии и/или предотвращения прогрессирования миопии, включающее тиотропий в качестве активного ингредиента
EA201890789A1 (ru) Содержащая цинеол композиция для лечения заболеваний носа
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
MX2018003381A (es) Profilactico o agente terapeutico para queratitis fungica.
CL2018000085A1 (es) Carbonitrilos de heteroarilo para el tratamiento de enfermedades
MX387252B (es) EL USO DE DERIVADOS DE QUINOLINONAS QUE TIENE UNA ACTIVIDAD DE INHIBICIÓN DE LA FORMACIÓN DEL COMPLEJO DE C-Myc/Max/ADN EN EL TRATAMIENTO DE CANCER.
UA106471U (uk) Засіб для лікування дерматологічних захворювань
UA106472U (uk) Засіб для лікування дерматологічних захворювань